Clinical Trial Update: Autologous Cord Blood Stem Cells for Autism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous cord blood stem cells for autism has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: Sutter Health | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2018-08-20